Efficacy, safety, and tolerability of GRT6005 in subjects with moderate to severe chronic low back pain

Update Il y a 4 ans
Reference: EUCTR2012-001920-36

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The objective of this trial is to assess the analgesic efficacy, safety, and tolerability of once daily orally administered GRT6005 in a total of 3 fixed doses (i.e., 200 μg, 400 μg, and 600 μg GRT6005) compared to placebo in subjects with moderate to severe chronic LBP.


Inclusion criteria

  • moderate to severe chronic low back pain